• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种来自人 B 细胞的针对流感病毒 H1N1 的有效中和抗体。

An Effective Neutralizing Antibody Against Influenza Virus H1N1 from Human B Cells.

机构信息

Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan.

Core Facility for Protein Production and X-ray Structural Analysis, Academia Sinica, Taipei, Taiwan.

出版信息

Sci Rep. 2019 Mar 14;9(1):4546. doi: 10.1038/s41598-019-40937-4.

DOI:10.1038/s41598-019-40937-4
PMID:30872685
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6418199/
Abstract

Influenza is a contagious acute respiratory disease caused by the influenza virus infection. Hemagglutinin (HA) is an important target in the therapeutic treatment and diagnostic detection of the influenza virus. Influenza A virus encompasses several different HA subtypes with different strains, which are constantly changing. In this study, we identified a fully human H1N1 neutralizing antibody (32D6) via an Epstein-Barr virus-immortalized B cell-based technology. 32D6 specifically neutralizes the clinically isolated H1N1 strains after the 2009 pandemic but not the earlier strains. The epitope was identified through X-ray crystallographic analysis of the 32D6-Fab/HA1 complex structure, which revealed a unique loop conformation located on the top surface of HA. The major region is composed of two peptide segments (residues 172-177 and 206-213), which form an abreast loop conformation. The residue T262 between the two loops forms a conformational epitope for recognition by 32D6. Three water molecules were observed at the interface of HA and the heavy chain, and they may constitute a stabilizing element for the 32D6-HA association. In addition, each 32D6-Fab is likely capable of blocking one HA trimer. This study provides important information on the strain specificity of 32D6 for the therapeutic treatment and detection of viral infection.

摘要

流感是由流感病毒感染引起的传染性急性呼吸道疾病。血凝素 (HA) 是流感病毒治疗和诊断检测的重要靶点。甲型流感病毒包含几种不同的具有不同株系的 HA 亚型,这些株系在不断变化。在这项研究中,我们通过基于 Epstein-Barr 病毒永生化 B 细胞的技术鉴定了一种全人源 H1N1 中和抗体 (32D6)。32D6 特异性中和 2009 年大流行后的临床分离的 H1N1 株,但不中和早期株。通过 32D6-Fab/HA1 复合物结构的 X 射线晶体学分析鉴定了表位,该分析揭示了位于 HA 顶面的独特环构象。主要区域由两个肽段(残基 172-177 和 206-213)组成,形成并列环构象。两个环之间的残基 T262 形成 32D6 识别的构象表位。在 HA 和重链的界面观察到三个水分子,它们可能构成 32D6-HA 结合的稳定元素。此外,每个 32D6-Fab 可能能够阻止一个 HA 三聚体。这项研究为 32D6 治疗病毒感染的治疗和检测提供了有关其株系特异性的重要信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7117/6418199/672270ff785b/41598_2019_40937_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7117/6418199/8528d3f3e560/41598_2019_40937_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7117/6418199/a54d3761ad5a/41598_2019_40937_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7117/6418199/3a0f6a70fa95/41598_2019_40937_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7117/6418199/672270ff785b/41598_2019_40937_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7117/6418199/8528d3f3e560/41598_2019_40937_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7117/6418199/a54d3761ad5a/41598_2019_40937_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7117/6418199/3a0f6a70fa95/41598_2019_40937_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7117/6418199/672270ff785b/41598_2019_40937_Fig4_HTML.jpg

相似文献

1
An Effective Neutralizing Antibody Against Influenza Virus H1N1 from Human B Cells.一种来自人 B 细胞的针对流感病毒 H1N1 的有效中和抗体。
Sci Rep. 2019 Mar 14;9(1):4546. doi: 10.1038/s41598-019-40937-4.
2
Conserved neutralizing epitope at globular head of hemagglutinin in H3N2 influenza viruses.H3N2流感病毒血凝素球状头部保守的中和表位
J Virol. 2014 Jul;88(13):7130-44. doi: 10.1128/JVI.00420-14. Epub 2014 Apr 9.
3
Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus.对 2009 年 H1N1 大流行流感病毒预先存在免疫的结构基础。
Science. 2010 Apr 16;328(5976):357-60. doi: 10.1126/science.1186430. Epub 2010 Mar 25.
4
Fully human broadly neutralizing monoclonal antibodies against influenza A viruses generated from the memory B cells of a 2009 pandemic H1N1 influenza vaccine recipient.源自 2009 年大流行 H1N1 流感疫苗接种者记忆 B 细胞的针对甲型流感病毒的全人源广谱中和单克隆抗体。
Virology. 2013 Jan 20;435(2):320-8. doi: 10.1016/j.virol.2012.09.034. Epub 2012 Oct 16.
5
Dissection of Epitope-Specific Mechanisms of Neutralization of Influenza Virus by Intact IgG and Fab Fragments.解析完整 IgG 和 Fab 片段对流感病毒中和作用的表位特异性机制。
J Virol. 2018 Feb 26;92(6). doi: 10.1128/JVI.02006-17. Print 2018 Mar 15.
6
A broadly neutralizing human monoclonal antibody directed against a novel conserved epitope on the influenza virus H3 hemagglutinin globular head.一种针对流感病毒 H3 血凝素球形头部上新的保守表位的广谱中和人源单克隆抗体。
J Virol. 2014 Jun;88(12):6743-50. doi: 10.1128/JVI.03562-13. Epub 2014 Apr 2.
7
Antibody recognition of the pandemic H1N1 Influenza virus hemagglutinin receptor binding site.抗体对大流行 H1N1 流感病毒血凝素受体结合位点的识别。
J Virol. 2013 Nov;87(22):12471-80. doi: 10.1128/JVI.01388-13. Epub 2013 Sep 11.
8
Alternative recognition of the conserved stem epitope in influenza A virus hemagglutinin by a VH3-30-encoded heterosubtypic antibody.甲型流感病毒血凝素保守茎部表位的异源种抗体的替代性识别。
J Virol. 2014 Jun;88(12):7083-92. doi: 10.1128/JVI.00178-14. Epub 2014 Apr 9.
9
Conformational Stability of the Hemagglutinin of H5N1 Influenza A Viruses Influences Susceptibility to Broadly Neutralizing Stem Antibodies.H5N1 流感病毒血凝素的构象稳定性影响对广谱中和茎部抗体的敏感性。
J Virol. 2018 May 29;92(12). doi: 10.1128/JVI.00247-18. Print 2018 Jun 15.
10
Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth.新型 H3 特异性广谱中和单克隆抗体的鉴定 该抗体靶向血凝素球状头部,来源于一位具有广泛血清学反应性的流感病毒免疫供者
J Virol. 2020 Feb 28;94(6). doi: 10.1128/JVI.01035-19.

引用本文的文献

1
Neutralization of the Pandemic Influenza A/H1N1 Virus with Humanized Nanobodies (VHH).利用人源化纳米抗体(VHH)中和甲型H1N1大流行性流感病毒
Antibodies (Basel). 2025 May 16;14(2):42. doi: 10.3390/antib14020042.
2
Evaluation of a novel intramuscular prime/intranasal boost vaccination strategy against influenza in the pig model.在猪模型中评估一种针对流感的新型肌肉注射初免/鼻内加强免疫接种策略。
PLoS Pathog. 2024 Aug 8;20(8):e1012393. doi: 10.1371/journal.ppat.1012393. eCollection 2024 Aug.
3
A synergistic therapy against influenza virus A/H1N1/PR8 by a HA1 specific neutralizing single-domain V and an RNA hydrolyzing scFv.

本文引用的文献

1
Detection of influenza A(H3N2) viruses exhibiting reduced susceptibility to the novel cap-dependent endonuclease inhibitor baloxavir in Japan, December 2018.日本 2018 年 12 月新型依赖于帽子结构的内切酶抑制剂 baloxavir 敏感性降低的甲型 H3N2 流感病毒的检测
Euro Surveill. 2019 Jan;24(3). doi: 10.2807/1560-7917.ES.2019.24.3.1800698.
2
Influenza Pathogenesis: The Effect of Host Factors on Severity of Disease.流感发病机制:宿主因素对疾病严重程度的影响。
J Immunol. 2019 Jan 15;202(2):341-350. doi: 10.4049/jimmunol.1801010.
3
Differences in the ease with which mutant viruses escape from human monoclonal antibodies against the HA stem of influenza A virus.
一种由HA1特异性中和单域V和RNA水解单链抗体片段组成的抗甲型H1N1/PR8流感病毒的协同疗法。
Front Microbiol. 2024 Apr 19;15:1355599. doi: 10.3389/fmicb.2024.1355599. eCollection 2024.
4
Adjuvant effects of combination monophosphoryl lipid A and poly I:C on antigen-specific immune responses and protective efficacy of influenza vaccines.联合单磷酰脂质 A 和聚肌苷酸胞苷酸对流感疫苗抗原特异性免疫应答和保护效力的佐剂作用。
Sci Rep. 2023 Jul 28;13(1):12231. doi: 10.1038/s41598-023-39210-6.
5
New Anti-Flavivirus Fusion Loop Human Antibodies with Zika Virus-Neutralizing Potential.新型抗黄病毒融合环人源抗体,具有中和寨卡病毒的潜力。
Int J Mol Sci. 2022 Jul 15;23(14):7805. doi: 10.3390/ijms23147805.
6
Polyclonal hyper immunoglobulin: A proven treatment and prophylaxis platform for passive immunization to address existing and emerging diseases.多克隆高免疫球蛋白:一种经过验证的被动免疫治疗和预防平台,可用于应对现有和新出现的疾病。
Hum Vaccin Immunother. 2022 Apr 29;18(2):1886560. doi: 10.1080/21645515.2021.1886560. Epub 2021 May 19.
7
iBRAB: In silico based-designed broad-spectrum Fab against H1N1 influenza A virus.基于计算机设计的广谱抗 H1N1 流感 A 病毒 Fab。
PLoS One. 2020 Dec 31;15(12):e0239112. doi: 10.1371/journal.pone.0239112. eCollection 2020.
8
Structural basis of polyethylene glycol recognition by antibody.抗体识别聚乙二醇的结构基础。
J Biomed Sci. 2020 Jan 7;27(1):12. doi: 10.1186/s12929-019-0589-7.
突变病毒逃避针对甲型流感病毒 HA 茎的人源单克隆抗体的能力存在差异。
J Clin Virol. 2018 Nov;108:105-111. doi: 10.1016/j.jcv.2018.09.016. Epub 2018 Sep 26.
4
Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents.巴洛沙韦玛波西利治疗成人和青少年单纯性流感。
N Engl J Med. 2018 Sep 6;379(10):913-923. doi: 10.1056/NEJMoa1716197.
5
Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil.描述使用内切酶抑制剂巴洛沙韦治疗诱导的流感病毒变异体。
Sci Rep. 2018 Jun 25;8(1):9633. doi: 10.1038/s41598-018-27890-4.
6
A Highly Potent and Broadly Neutralizing H1 Influenza-Specific Human Monoclonal Antibody.一种高效且广谱中和的 H1 型流感特异性人源单克隆抗体。
Sci Rep. 2018 Mar 12;8(1):4374. doi: 10.1038/s41598-018-22307-8.
7
Structural Insight into a Human Neutralizing Antibody against Influenza Virus H7N9.对一种抗H7N9流感病毒的人源中和抗体的结构洞察
J Virol. 2018 Feb 12;92(5). doi: 10.1128/JVI.01850-17. Print 2018 Mar 1.
8
High throughput discovery of influenza virus neutralizing antibodies from phage-displayed synthetic antibody libraries.高通量筛选噬菌体展示合成抗体文库中的流感病毒中和抗体。
Sci Rep. 2017 Oct 31;7(1):14455. doi: 10.1038/s41598-017-14823-w.
9
Residues Comprising the Enhanced Aromatic Sequon Influence Protein N-Glycosylation Efficiency.包含增强芳香序列的残基影响蛋白质 N-糖基化效率。
J Am Chem Soc. 2017 Sep 20;139(37):12947-12955. doi: 10.1021/jacs.7b03868. Epub 2017 Sep 6.
10
Drug resistance in influenza A virus: the epidemiology and management.甲型流感病毒的耐药性:流行病学与管理
Infect Drug Resist. 2017 Apr 20;10:121-134. doi: 10.2147/IDR.S105473. eCollection 2017.